Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: Moderate Risk
2C-I carries a moderate risk profile. Acute and chronic risks depend significantly on dose, frequency, route of administration, and individual predispositions.
Neurotoxicity
none_known
The following substances carry an elevated risk of adverse interactions with 2C-I. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
general
2C-I gilt als milder als 2C-E — trotzdem körperlich anspruchsvoll und mentale Vorbereitung wichtig
dosing
Oral: 10–20 mg für Erstanwender. Wirkungseintritt 60–90 Minuten
setting
Set & Setting: ruhige Umgebung, vertraute Personen — Visuals können intensiv sein
combinations
Kein Lithium, keine MAO-Hemmer
health
Stimulierende Komponente (Phenethylamin) beachten: Herzfrequenz und Blutdruck steigen
dosing
Toleranzentwicklung: mind. 1 Woche Pause nach jeder Erfahrung
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.